These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 5807593)
41. [Dicloxacillin: a new semisynthetic penicillin. Study of the serum concentrations in comparison with oxacillin]. Scioli C; Fiorentino F Rass Int Clin Ter; 1967 Feb; 47(3):119-24. PubMed ID: 5600881 [No Abstract] [Full Text] [Related]
42. [Separation and determination of ampicillin in combination with cloxacillin or dicloxacillin]. Saccani F; Neri C; Sudano F Boll Chim Farm; 1969 Dec; 108(12):777-80. PubMed ID: 5374883 [No Abstract] [Full Text] [Related]
43. Effect of dicloxacillin, oxacillin, and nafcillin upon staphylococcal population and rate of healing of soft-tissue lesions. Hartman RE; Carleton J; Lustberg A; Hamburger M Antimicrob Agents Chemother (Bethesda); 1966; 6():64-8. PubMed ID: 5985303 [No Abstract] [Full Text] [Related]
44. Large-volume sample stacking combined with separation by 2-hydroxypropyl-beta-cyclodextrin for analysis of isoxyzolylpenicillins by capillary electrophoresis. Zhu Z; Zhang L; Marimuthu A; Yang Z Electrophoresis; 2003 Sep; 24(17):3089-96. PubMed ID: 12973814 [TBL] [Abstract][Full Text] [Related]
45. [Pharmacological study of oxacillin and cloxacillin]. Veĭs RA; Storozhev IA Antibiotiki; 1966 Dec; 11(12):1106-9. PubMed ID: 5998699 [No Abstract] [Full Text] [Related]
46. Clinical, laboratory, and pharmacological studies of dicloxacillin. Hammerstrom CF; Cox F; McHenry MC; Quinn EL Antimicrob Agents Chemother (Bethesda); 1966; 6():69-74. PubMed ID: 5982342 [No Abstract] [Full Text] [Related]
47. [Clinical uses of Dicloxacillin (Staphcillin-A)--staphylococcal sensitivity and clinical effects]. Tachibana K; Yamada M; Takeda T; Ogawa Y Hifuka Kiyo; 1966 Nov; 61(4):334-6. PubMed ID: 6009649 [No Abstract] [Full Text] [Related]
48. [Circulation of isoxazolyl penicillins in surgical patients]. Iakovlev VP; Kopeĭko IP; Govorovich EA; Marshak AM; Nikishina OP Antibiotiki; 1971 Oct; 16(10):944-8. PubMed ID: 5138889 [No Abstract] [Full Text] [Related]
49. Serum levels of penicillins: a pharmacokinetic view. Gibaldi M; Schwartz MA; Plaut ME Antimicrob Agents Chemother (Bethesda); 1968; 8():378-81. PubMed ID: 5735384 [No Abstract] [Full Text] [Related]
50. [The effect of a mezlocillin-oxacillin combination on ADP-induced thrombocyte aggregation in vitro]. Menz G Med Welt; 1981 Oct; 32(42):1584-5. PubMed ID: 6458750 [No Abstract] [Full Text] [Related]
51. Reaction of meristematic cells to penicillin, cloxacillin and streptomycin. Dobrzyńska K; Podbielkowska M Acta Pol Pharm; 1991; 48(1-2):61-6. PubMed ID: 1669423 [No Abstract] [Full Text] [Related]
57. Serum levels, urinary recovery, and safety of dicloxacillin, a new semisynthetic penicillin, in normal volunteers. De Felice EA J Clin Pharmacol J New Drugs; 1967; 7(5):275-7. PubMed ID: 5237374 [No Abstract] [Full Text] [Related]
58. Hospital staphylococci and the new penicillins. Barber M Minerva Med; 1965 Sep; 56(73 Suppl):3058-9. PubMed ID: 5838809 [No Abstract] [Full Text] [Related]
59. Phenytoin-oxacillin interactions in normal and uremic sera. Dasgupta A; Sperelakis A; Mason A; Dean R Pharmacotherapy; 1997; 17(2):375-8. PubMed ID: 9085332 [TBL] [Abstract][Full Text] [Related]
60. New screening medium for detection and identification of methicillin/oxacillin-resistant Staphylococcus aureus for nosocomial surveillance. Merlino J; Watson J; Funnell G; Gottlieb T; Bradbury R; Harbour C Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):414-6. PubMed ID: 12072932 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]